Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WPYAS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
OBI-992
|
|||||
| Synonyms |
BSI 04702; BSI-04702; BSI-992; BSI04702; OBI 992; OBI992
Click to Show/Hide
|
|||||
| Organization |
Biosion, Inc.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
R4702
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Mal-PEG24-Val-Ala-PABC
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
